USD10
PLRX Shares
About Pliant TherapeuticsPliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
USD10
PLRX Shares
About Pliant TherapeuticsPliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$64.4M
OPEN PRICE
$1.06
LOW (1Y)
$1.05
HIGH (1Y)
$1.95
LOW (24H)
$1.04
HIGH (24H)
$1.08
VOLUME (24H)
$334.1K
92.55%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.06 | |
1 Day | $1.09 | |
1 Week | $1.10 | |
1 Month | $1.17 | |
1 Year | Not enough data | Not enough data |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.